Development of Long Circulating Enzyme Replacement Therapy for MPS IVA.
Mucopolysaccharidosis type IVA (MPS IVA) results from a deficiency of the enzyme N-acetylgalactoseamine- 6-sulfate sulfatase. This enzyme is required for the breakdown of complex sugars called “glycosaminoglycans (GAGs).” GAGs are … Continued